Daniel Griffin provides his weekly clinical report on COVID-19, including new post-exposure guidelines from CDC, clinical trials of Remdesivir and convalescent plasma, FDA EUA for baricitinib and Regeneron's monoclonal antibody and more.

Hosts: Daniel Griffin and Vincent Racaniello

Subscribe (free): iTunes, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• WHO Solidarity trial for Remdesivir and other drugs (medRxiv)
• EUA for Baricitinib (FDA)
• EUA for Casirivimab and Imdevimab (FDA)
• RCT: No benefit of convalescent plasma (NEJM)
• Letters read on TWiV 686
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees Send your virology questions and comments to [email protected]